Prospects of IL-2 in Cancer Immunotherapy
Joint Authors
Rasool, Mahmood
Choudhry, Hani
Zamzami, Mazin A.
Wu, Wei
Abdulaal, Wesam H.
Helmi, Nawal
Zeyadi, Mustafa
Warsi, Mohiuddin K.
Jamal, Mohammad Sarwar
Mahmoud, Maged Mostafa
Source
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-05-06
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
IL-2 is a powerful immune growth factor and it plays important role in sustaining T cell response.
The potential of IL-2 in expanding T cells without loss of functionality has led to its early use in cancer immunotherapy.
IL-2 has been reported to induce complete and durable regressions in cancer patients but immune related adverse effects have been reported (irAE).
The present review discusses the prospects of IL-2 in immunotherapy for cancer.
American Psychological Association (APA)
Choudhry, Hani& Helmi, Nawal& Abdulaal, Wesam H.& Zeyadi, Mustafa& Zamzami, Mazin A.& Wu, Wei…[et al.]. 2018. Prospects of IL-2 in Cancer Immunotherapy. BioMed Research International،Vol. 2018, no. 2018, pp.1-7.
https://search.emarefa.net/detail/BIM-1129459
Modern Language Association (MLA)
Choudhry, Hani…[et al.]. Prospects of IL-2 in Cancer Immunotherapy. BioMed Research International No. 2018 (2018), pp.1-7.
https://search.emarefa.net/detail/BIM-1129459
American Medical Association (AMA)
Choudhry, Hani& Helmi, Nawal& Abdulaal, Wesam H.& Zeyadi, Mustafa& Zamzami, Mazin A.& Wu, Wei…[et al.]. Prospects of IL-2 in Cancer Immunotherapy. BioMed Research International. 2018. Vol. 2018, no. 2018, pp.1-7.
https://search.emarefa.net/detail/BIM-1129459
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1129459
